BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20974656)

  • 1. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
    Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
    Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
    Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
    Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.
    Yang J; Pospisil R; Ray S; Milton J; Mage RG
    PLoS One; 2009 Dec; 4(12):e8494. PubMed ID: 20041151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
    Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
    Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.
    Jacob CO; Yu N; Sindhava V; Cancro MP; Pawar RD; Putterman C; Stohl W
    Arthritis Rheumatol; 2015 Sep; 67(9):2523-35. PubMed ID: 25989238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of BLyS on the activity of peripheral B lymphocytes mediated by BLyS receptors in patients with systemic lupus erythematosus.
    Cheng Y; Yan S; Zhao W; Huang Q; Lian L; Wei W
    Scand J Clin Lab Invest; 2013 Mar; 73(2):141-7. PubMed ID: 23336587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.
    Vincent FB; Saulep-Easton D; Figgett WA; Fairfax KA; Mackay F
    Cytokine Growth Factor Rev; 2013 Jun; 24(3):203-15. PubMed ID: 23684423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF system expression in double negative 2, activated naïve and activated memory B cells in systemic lupus erythematosus.
    Álvarez Gómez JA; Salazar-Camarena DC; Román-Fernández IV; Ortiz-Lazareno PC; Cruz A; Muñoz-Valle JF; Marín-Rosales M; Espinoza-García N; Sagrero-Fabela N; Palafox-Sánchez CA
    Front Immunol; 2023; 14():1235937. PubMed ID: 37675114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies.
    López De Padilla CM; McNallan KT; Crowson CS; Bilgic H; Bram RJ; Hein MS; Ytterberg SR; Amin S; Peterson EJ; Baechler EC; Reed AM
    J Rheumatol; 2013 Mar; 40(3):294-302. PubMed ID: 23322463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.
    Ortiz-Aljaro P; Montes-Cano MA; García-Lozano JR; Aquino V; Carmona R; Perez-Florido J; García-Hernández FJ; Dopazo J; González-Escribano MF
    Sci Rep; 2022 Jul; 12(1):11219. PubMed ID: 35780200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.
    Schuepbach-Mallepell S; Das D; Willen L; Vigolo M; Tardivel A; Lebon L; Kowalczyk-Quintas C; Nys J; Smulski C; Zheng TS; Maskos K; Lammens A; Jiang X; Hess H; Tan SL; Schneider P
    J Biol Chem; 2015 Jun; 290(26):16330-42. PubMed ID: 25953898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
    Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
    J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
    Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
    Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
    Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
    Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of BAFF and its receptors' expression in lupus nephritis is associated with pathological classes.
    Suso JP; Posso-Osorio I; Jiménez CA; Naranjo-Escobar J; Ospina FE; Sánchez A; Cañas CA; Tobón GJ
    Lupus; 2018 Apr; 27(5):708-715. PubMed ID: 29087261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.